Halfway through earnings season and analysts at BMO Capital Markets have noticed the following themes regarding MedTech companies:
- Q2 has no clear theme of upward revisions, like what the market saw in Q1
- Companies with large market cap have beat revenue, and virtually all have beaten EPS estimates also
In a note to investors, BMO highlighted earnings this week in MedTech, noting that they are now focusing more on small-cap names.
Monday 8/1
- Haemonetics Corporation HAE - Reported pre-market (PM), Q1 EPS $0.25 vs $0.29 estimated, revenues of $209.96M vs $205.24M estimated
- Glaukos Corp GKOS - After hours (AH)
- Orthofix International NV OFIX - AH
Tuesday 8/2
- Mazor Robotics Ltd MZOR - PM
- Wright Medical Group WMGI - AH
- Endologix, Inc ELGX - AH
- DexCom, Inc DXCM - AH
- Intersect ENT Inc XENT - AH
Wednesday 8/3
- Insulet Corporation PODD - AH
- STAAR Surgical Company STAA - AH
- Cardiovascular Systems Inc CSII - AH
- K2M Group Holdings Inc KTWO - AH
Thursday 8/4
- Becton Dickinson and Co BDX - PM
- Hill-Rom Holdings, Inc HRC - PM
- Rewalk Robotics Ltd RWLK - PM
- DENTSPLY SIRONA Inc XRAY - PM
- AtriCure Inc ATRC - AH
BMO expects fundamental to be in the spotlight as the remainder of earnings season unfolds.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorAnalyst Ratings
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in